|
|
Volumn 18, Issue SUPPL. 3, 2007, Pages
|
|
Market uptake of new oncology drugs
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
ERLOTINIB;
EXEMESTANE;
FLUOROURACIL;
FOLINATE CALCIUM;
GEMCITABINE;
HYDROXYUREA;
IMATINIB;
IRINOTECAN;
LETROZOLE;
MEGESTROL;
METHOTREXATE;
NAVELBINE;
NEW DRUG;
OXALIPLATIN;
PACLITAXEL;
PEMETREXED;
TAXANE DERIVATIVE;
TEGAFUR;
TRASTUZUMAB;
UNINDEXED DRUG;
ADD ON THERAPY;
ADJUVANT THERAPY;
ARTICLE;
AUSTRIA;
COLORECTAL CANCER;
CZECH REPUBLIC;
DRUG COST;
DRUG MARKETING;
FRANCE;
HUMAN;
LUNG CANCER;
NEW ZEALAND;
POLAND;
PRIORITY JOURNAL;
SOUTH AFRICA;
SWITZERLAND;
UNITED KINGDOM;
UNITED STATES;
|
|
EID: 54349088047
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdm099 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|